Franklin Resources
VTVT icon

Franklin Resources’s vTv Therapeutics VTVT Stock Holding History

Franklin Resources’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-20,883
Closed -$3.4M – 1542
2018
Q1 		$3.4M Sell
20,883
-370
-2% -$90.6K ﹤0.01% 1107
2017
Q4 		$5.11M Sell
21,253
-1,225
-5% -$275K ﹤0.01% 1063
2017
Q3 		$5.38M Hold
22,478
– – ﹤0.01% 1053
2017
Q2 		$4.47M Sell
22,478
-1,345
-6% -$280K ﹤0.01% 1097
2017
Q1 		$6.24M Hold
23,823
– – ﹤0.01% 1067
2016
Q4 		$4.6M Hold
23,823
– – ﹤0.01% 1100
2016
Q3 		$6.85M Hold
23,823
– – ﹤0.01% 1054
2016
Q2 		$5.53M Hold
23,823
– – ﹤0.01% 1086
2016
Q1 		$4.92M Hold
23,823
– – ﹤0.01% 1102
2015
Q4 		$6.49M Hold
23,823
– – ﹤0.01% 1085
2015
Q3 		$6.21M Buy
+23,823
New +$8.3M ﹤0.01% 1105

Other funds holding VTVT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return

Franklin Resources's VTVT Position: Q2 2018 in Review

Franklin Resources sold out of vTv Therapeutics (VTVT) in Q2 2018, closing a stake of 20,883 shares — an estimated $3.4M sold.

Franklin Resources first reported a position in VTVT in Q3 2015 and held it in 11 quarters. The position peaked at $6.85M in Q3 2016. 27 funds tracked by Wall St. Rank hold VTVT as of Q2 2018.

  • Franklin Resources reported no remaining vTv Therapeutics position as of Q2 2018 after selling out during the quarter.
  • Franklin Resources sold 20,883 vTv Therapeutics shares in Q2 2018, an estimated $3.4M.
  • Franklin Resources first reported a position in vTv Therapeutics in Q3 2015 and held it in 11 quarters.
  • Franklin Resources's vTv Therapeutics position peaked at $6.85M in Q3 2016.
  • 27 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2018.

Based on Franklin Resources's 13F filing for Q2 2018, filed 14 Aug 2018.